Efficacy and safety of bivalirudin versus heparin in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Efficacy and safety of bivalirudin versus heparin in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials

Published:2016-04 Issue: Volume:209 Page:87-95
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Zhang Shuo,Gao Weihua,Li Haixia,Zou Meijuan,Sun Sihao,Ba Yijie,Liu Yang,Cheng Gang

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. Guidelines in review: 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction;Ghimire;J Nucl Cardiol,2014

2. The bivalirudin paradox: high evidence, low use;De Servi;J Cardiovasc Med,2013

3. Comparison of prolonged bivalirudin infusion versus intraprocedural in preventing myocardial damage after percutaneous coronary intervention in patients with angina pectoris;Cortese;Am J Cardiol,2009

4. Quality of reporting of systematic reviews and meta-analyses: PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses);Walther;RoFo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,2011

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation;Expert Opinion on Pharmacotherapy;2023-02-07

2. Guía ESC 2020 sobre el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST;Revista Española de Cardiología;2021-06

3. 2020 Clinical practice guidelines for Acute coronary syndrome without ST segment elevation;Russian Journal of Cardiology;2021-05-22

4. Bivalirudin in patients undergoing percutaneous coronary intervention and independent predictors of postoperative adverse events in these patients;Medicine;2021-03-12

5. Practicability of Bivalirudin plus Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis;Clinical and Applied Thrombosis/Hemostasis;2021-01